Form 4 for TMDX TransMedics Group, Inc.
Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-04 · accession 0000950170-24-026478 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-03-05 | 2024-03-04 | TMDX | Gordon Stephen | CFO | M - OptEx | $38.46 | +15.0K | 40.2K | +60% | +$576.9K |
| DT | 2024-03-05 | 2024-03-04 | TMDX | Gordon Stephen | CFO | S - Sale+OE | $82.80 | -15.0K | 25.2K | -37% | -$1.24M |
| DT | 2024-03-05 | 2024-03-04 | TMDX | Gordon Stephen | CFO | M - OptEx | $0.00 | -15.0K | 52.5K | -22% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-04 | M | A | 15,000 | $38.46 | 40,202 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-04 | S | D | 15,000 | $82.80 | 25,202 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-03-04 | M | D | 15,000 | $0.00 | 52,477 | D | $38.46 · — to 2031-02-24 | 15,000 Common Stock | (F2) The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025. |